Amorsa Therapeutics - Articles and news items

Amorsa to collaborate with J&J on treatment-resistant depression therapy

Industry news / 5 January 2017 / Niamh Marriott, Digital Editor

Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+